Pharmaceuticals & Biotechnology (4570)

21,228.55
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Aptamer signs second Optimer programme contract with Unilever

By Iain Gilbert

Date: Friday 30 May 2025

(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.

Hvivo client cancels 'significant' HCT trial contract

By Iain Gilbert

Date: Friday 30 May 2025

(Sharecast News) - Contract research organisation Hvivo has received notification that "a significant human challenge trial" contract has been cancelled, alongside a postponement and the cancellation of a smaller study.

Sareum starts toxicology studies for lead inhibitor

By Josh White

Date: Thursday 29 May 2025

(Sharecast News) - Sareum announced the start of a programme of toxicology studies on Thursday, for its lead TYK2/JAK1 inhibitor - SDC-1801 - marking a key step toward phase two clinical development.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,228.55
Closing Price Change 545.13
% Change 2.64 %
30-May-25 Close 21,228.55

Top Risers

Price Change
CIZ 2.35p +23.7%
APTA 0.38p +10.3%
FARN 262.50p +7.1%
SCLP 10.00p +5.3%
HELD 0.99p +4.2%
INDV 944.50p +4.0%
GSK 1,507.00p +3.5%
AZN 10,720.00p +3.1%
AGY 7.10p +2.9%
BXP 37.00p +2.8%

Top Fallers

Price Change
NFX 0.11p -6.4%
IXI 11.25p -6.3%
OBI 8.50p -5.6%
SAR 14.25p -5.0%
GENF 0.85p -2.9%
ANCR 280.00p -2.1%
STX 2.40p -2.0%
OPTI 14.50p -1.7%
BMK 24.00p -0.8%
ANIC 6.20p -0.8%

Top of Page